Related Experiment Videos
Intestinal absorption of dideoxynucleosides: characterization using a multiloop in situ technique
1Controlled Drug-Delivery Research Center, Rutgers, State University of New Jersey, College of Pharmacy.
Journal of Pharmaceutical Sciences
|January 1, 1995
Summary
Dideoxynucleoside absorption varies by intestinal region. 3'-azido-2',3'-dideoxythymidine absorbed best in the ileum, while 2',3'-dideoxyinosine and 2',3'-dideoxycytidine preferred the jejunum.
Area of Science:
- Pharmacokinetics
- Gastrointestinal Physiology
- Drug Absorption
Background:
- Dideoxynucleosides are crucial antiviral agents.
- Understanding their intestinal absorption is vital for optimizing drug delivery.
- Regional differences in absorption can significantly impact bioavailability.
Purpose of the Study:
- To characterize the intestinal absorption kinetics of dideoxynucleosides in rabbits.
- To determine the influence of different intestinal regions on dideoxynucleoside absorption.
- To validate absorption data using a mass-balance approach.
Main Methods:
- Utilized a closed-loop mesenteric-sampling in situ technique in rabbits.
- Investigated absorption across various intestinal segments (ileum, jejunum).
- Quantified drug retention, degradation, and systemic distribution.
Main Results:
- 3 -azido-2 -dideoxythymidine showed maximal absorption in the ileum.
- 2 ',3 -dideoxyinosine and 2 ',3 -dideoxycytidine were preferentially absorbed from the jejunum.
- Mass-balance studies confirmed regional absorption differences and assessed drug fate.
Conclusions:
- Intestinal absorption of dideoxynucleosides is region-specific.
- Absorption patterns differ among individual dideoxynucleosides.
- These findings are critical for developing effective dideoxynucleoside-based therapies.